078054814	078054814	CD	B-NP	O
|	|	NN	I-NP	O
TMEAH	TMEAH	NN	I-NP	O
|	|	NN	I-NP	O
63511491	63511491	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2711793	2711793	CD	B-NP	O
|	|	CC	I-NP	O
5/30/2006	5/30/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/28/2006	5/28/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/13/2006	8/13/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
KAI	KAI	NNP	B-NP	O
,	,	,	O	O
KEITH	KEITH	NNP	B-NP	O
284-98-55-6	284-98-55-6	CD	I-NP	O
O	O	NNP	I-NP	O
A	A	NNP	I-NP	O
Do	Do	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/27/06	8/27/06	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WENSKOSKI	WENSKOSKI	NNP	B-NP	O
,	,	,	O	O
STANTON	STANTON	NNP	B-NP	O
SID	SID	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	B-protein
81	81	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/28	6/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/24/06	4/24/06	CD	B-NP	O
by	by	IN	B-PP	O
BRINKMANN	BRINKMANN	NN	B-NP	O
,	,	,	O	O
ROLANDO	ROLANDO	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
832488821	832488821	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
LIPITOR	LIPITOR	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/27/06	8/27/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/28	6/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/24/06	4/24/06	CD	B-NP	O
by	by	IN	B-PP	O
HEIMERDINGER	HEIMERDINGER	NN	B-NP	B-protein
,	,	,	O	O
NOEL	NOEL	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ERYTHROMYCIN	ERYTHROMYCIN	NN	B-NP	B-protein
OPHTHALMIC	OPHTHALMIC	NN	I-NP	I-protein
OINTMENT	OINTMENT	NN	I-NP	I-protein
OU	OU	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
845794197	845794197	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
ERYTHROMYCIN	ERYTHROMYCIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/28	6/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
40	40	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
30	30	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
SC	SC	NNP	I-NP	O
40	40	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
30	30	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
IMDUR	IMDUR	NNP	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/27/06	8/27/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/28	6/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
ALDACTONE	ALDACTONE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/8/06	3/8/06	CD	B-NP	O
by	by	IN	B-PP	O
KRIEG	KRIEG	NN	B-NP	B-protein
,	,	,	O	O
OLEN	OLEN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
386246762	386246762	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	B-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/24/06	4/24/06	CD	B-NP	O
by	by	IN	B-PP	O
GLAZNER	GLAZNER	NNP	B-NP	O
,	,	,	O	O
LORENZO	LORENZO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
SPIRONOLACTONE	SPIRONOLACTONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Chauncey	Chauncey	NNP	I-NP	O
Patock	Patock	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CH	CH	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/21/06	1/21/06	CD	I-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Burl	Burl	NNP	I-NP	O
Banowski	Banowski	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
next	next	JJ	B-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Talpaz	Talpaz	NNP	B-NP	O
Cum-ope	Cum-ope	NNP	I-NP	O
Enwill	Enwill	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Endocrinology	Endocrinology	NNP	I-NP	O
-	-	:	O	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
on	on	IN	B-PP	O
monday	monday	NN	B-NP	O
4/12	4/12	CD	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointmen	appointman	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CARDIOMYOPATHY-EF	CARDIOMYOPATHY-EF	NNP	I-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
ASTHMA	ASTHMA	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hx	hx	NN	B-NP	O
ETOH	ETOH	NNP	I-NP	O
ABUSE	ABUSE	NNP	I-NP	O
,	,	,	O	O
INSULIN	INSULIN	NNP	B-NP	B-protein
REQ	REQ	NNP	I-NP	O
TYPE	TYPE	NNP	I-NP	O
II	II	NNP	I-NP	O
DM	DM	NNP	I-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
8/6	8/6	CD	B-NP	O
Left	Left	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Catherization	Catherization	NNP	I-NP	O
9/29	9/29	CD	I-NP	O
Right	Right	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Catherization	Catherization	NNP	I-NP	O
Please	Please	NNP	I-NP	O
see	see	VBP	B-VP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
for	for	IN	B-PP	O
salient	salient	JJ	B-NP	B-cell_type
details	detail	NNS	I-NP	I-cell_type
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
CC	CC	NN	I-NP	O
/	/	SYM	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
Dx	Dx	NN	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
**	**	SYM	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
45M	45M	NN	B-NP	O
with	with	IN	B-PP	O
non-DCM	non-DCM	JJ	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
EF25	EF25	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	O
p/w	p/w	NN	I-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
/	/	SYM	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
PND	PND	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
?	?	.	O	O

chest	ch	JJS	B-NP	O
tightness	tightness	NN	I-NP	O
on	on	IN	B-PP	O
AM	AM	NN	B-NP	O
of	of	IN	B-PP	O
admit	admit	NN	B-NP	B-protein
-RRB-	-RRB-	HYPH	O	I-protein
likely	likely	RB	B-ADJP	O
2/2	2/2	CD	B-NP	O
to	to	TO	B-PP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
and	and	CC	I-NP	O
medical	medical	JJ	I-NP	O
noncompliance	noncompliance	NN	I-NP	O
.	.	.	O	O

Treated	Treat	VBN	B-VP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
aldactone	aldactone	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
from	from	IN	B-PP	O
NRB	NRB	NN	B-NP	B-protein
to	to	TO	B-PP	O
2L	2L	NN	B-NP	O
by	by	IN	B-PP	O
NC	NC	NN	B-NP	B-cell_type
.	.	.	O	O

**	**	SYM	O	O
RELEVANT	RELEVANT	NN	B-NP	O
PMHX	PMHX	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
DCM	DCM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EtOH	EtOH	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
EF	EF	NN	I-NP	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
5/27	5/27	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Long	Long	NNP	I-NP	O
Stvrestil	Stvrestil	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
angiography	angiography	NN	I-NP	O
1995	1995	CD	I-NP	O
with	with	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-VP	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	B-protein
-RRB-	-RRB-	SYM	B-VP	I-protein
-	-	HYPH	B-NP	O
HTN	HTN	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
DMII	DMII	NN	I-NP	O
-	-	HYPH	B-NP	O
OSA	OSA	NN	I-NP	B-protein
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Asthma	Asthma	NN	I-NP	O
**	**	SYM	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	SYM	B-NP	O
PCN	PCN	NN	I-NP	O
-LRB-	-LRB-	SYM	I-NP	O
rash	rash	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
**	**	SYM	B-NP	O
HOME	HOME	NN	I-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
Dig	Dig	NNP	B-NP	O
0	0	CD	I-NP	O
.	.	.	O	O

l25	l25	CD	B-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
Glipizide	Glipizide	NNP	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
Metformin	Metformin	NNP	B-NP	O
500	500	CD	I-NP	O
TID	TID	NNP	I-NP	O
,	,	,	I-NP	O
Insulin	Insulin	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
40	40	CD	I-NP	O
QAM/30	QAM/30	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
Aldaction	Aldaction	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
**	**	SYM	I-NP	O
DAILY	DAILY	NN	I-NP	O
STATUS/EXAM	STATUS/EXAM	NN	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	B-protein
5/14	5/14	CD	I-NP	I-protein
AF	AF	NN	I-NP	I-protein
,	,	,	O	O
P70-100	P70-100	NN	B-NP	B-protein
,	,	,	O	O
BP90-110	BP90-110	NN	B-NP	O
/	/	SYM	B-VP	O
60-70	60-70	NN	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
94	94	CD	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
distant	distant	JJ	B-NP	O
,	,	,	I-NP	O
RRR	RRR	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
noted	note	VBD	B-VP	O
ABD	ABD	NN	B-NP	O
:	:	:	O	O
S/NT/ND	S/NT/ND	NN	B-NP	O
EXTR	EXTR	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
mid-calf	mid-calf	JJ	B-NP	O
bilat	bilat	NN	I-NP	O
,	,	,	O	O
warm	warm	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
NEURO	NEURO	NN	I-NP	B-protein
:	:	:	O	O
AOx3	AOx3	NN	B-NP	B-protein
,	,	,	O	O
non-focal	non-focal	JJ	B-NP	O
**	**	SYM	I-NP	O
TESTS/PROCEDURES	TESTS/PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
8/6	8/6	CD	B-NP	O
LHC	LHC	NN	I-NP	O
showed	show	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
3vd	3vd	NN	B-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	O
RHC	RHC	NN	I-NP	O
releaved	releave	VBD	B-VP	O
elevated	elevated	JJ	B-NP	O
left	left	JJ	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
transpulmonary	transpulmonary	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
CONSULTS	CONSULTS	NNS	I-NP	O
:	:	:	O	O
ACE	ACE	NN	B-NP	O
,	,	,	O	O
SS	SS	NN	B-NP	O
,	,	,	O	O
nutrition	nutrition	NN	B-NP	O
**	**	SYM	I-NP	O
Hospital	Hospital	NN	I-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
CV/I	CV/I	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
sucessfully	sucessfully	RB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
for	for	IN	B-PP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continuedon	continuedon	VBG	I-VP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
BB	BB	NN	B-NP	B-protein
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
deterioration	deterioration	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
CAD	CAD	NN	B-NP	B-protein
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
study	study	NN	I-NP	O
5	5	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
3vd	3vd	VBN	I-VP	O
disease	disease	NN	B-NP	O
with	with	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
RT	RT	NN	I-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
,	,	,	O	O
RT	RT	NN	B-NP	B-protein
LV-VR	LV-VR	NN	I-NP	I-protein
,	,	,	O	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
Lcx	Lcx	NN	B-NP	B-protein
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
echocardiographic	echocardiographic	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
proceeded	proceed	VBD	B-VP	O
the	the	DT	B-NP	O
progression	progression	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
CAD	CAD	NN	I-NP	B-protein
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
arteriosclerosis	arteriosclerosis	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
imparied	imparied	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
performance	performance	NN	I-NP	O
though	though	IN	B-SBAR	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
disease	disease	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

CV/P	CV/P	NN	B-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
excellent	excellent	JJ	I-NP	O
reponse	reponse	NN	I-NP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
home	home	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
6/3	6/3	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
right	right	JJ	B-NP	O
and	and	CC	I-NP	O
left	left	JJ	I-NP	O
sided	side	VBD	B-VP	O
filling	filling	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Pcw	Pcw	NN	I-NP	B-protein
of	of	IN	B-PP	O
24	24	CD	B-NP	O
and	and	CC	O	O
mean	mean	JJ	B-NP	O
RA	RA	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Imdur	Imdur	NNP	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	B-protein
CV/R	CV/R	NN	I-NP	I-protein
:	:	:	O	O
Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
undergoing	undergo	VBG	I-VP	O
evaulation	evaulation	NN	B-NP	O
for	for	IN	B-PP	O
ICD	ICD	NN	B-NP	B-protein
.	.	.	O	O

NO	NO	NN	B-NP	O
ectopy	ectopy	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
during	during	IN	B-PP	O
full-time	full-time	JJ	B-NP	O
telemetric	telemetric	JJ	I-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
OSA	OSA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
6	6	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
active	active	JJ	I-NP	O
asthma	asthma	NN	I-NP	O
rx	rx	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	VBZ	B-VP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
off	off	RP	B-PRT	O
his	his	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
300s	300	NNS	I-NP	B-DNA
.	.	.	O	O

His	His	PRP$	B-NP	O
Last	Last	JJ	I-NP	O
A1C	A1C	NN	I-NP	B-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
9.5	9.5	CD	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	IN	B-PRT	O
and	and	CC	O	O
drug	drug	NN	B-NP	O
therapy	therapy	NN	I-NP	O
discontinued	discontinue	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
BID	BID	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
to	to	TO	B-VP	O
replace	replace	VB	I-VP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
med/insulin	med/insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

WSRH	WSRH	NN	B-NP	O
outpatient	outpatient	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
services	service	NNS	I-NP	O
follow-up	follow-up	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
for	for	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
On	On	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
with	with	IN	B-PP	O
admit	admit	NN	B-NP	O
INR	INR	NN	I-NP	O
1.1	1.1	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
instructed	instruct	VBN	B-VP	O
to	to	TO	B-VP	O
discontinue	discontinue	VB	I-VP	O
medication	medication	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
considering	consider	VBG	B-VP	O
no	no	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
afib	afib	NN	B-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
throbus	throbus	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
DVT/clot	DVT/clot	NN	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
questions	question	NNS	B-NP	O
with	with	IN	B-PP	O
medication	medication	NN	B-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

F/E/N	F/E/N	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
on	on	IN	B-PP	O
proper	proper	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
and	and	CC	I-NP	O
HF	HF	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

PSYCH/SOCIAL	PSYCH/SOCIAL	NN	B-NP	O
:	:	:	O	O
Hx	Hx	NN	B-NP	O
EtOH	EtOH	NN	I-NP	O
abuse	abuse	NN	I-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
drink	drink	NN	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admit	admit	NN	B-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
cocaine-using	cocaine-using	JJ	B-NP	O
brother	brother	NN	I-NP	O
hough	hough	NN	I-NP	O
pt	pt	NN	I-NP	O
denies	deny	VBZ	B-VP	O
use	use	NN	B-NP	O
.	.	.	O	O

UTox	UTox	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

SMC	SMC	NN	B-NP	O
consult	consult	NN	I-NP	O
provided	provide	VBD	B-VP	O
listing	listing	NN	B-NP	O
of	of	IN	B-PP	O
Spanish	Spanish	JJ	B-NP	O
AA	AA	NN	I-NP	O
meetings	meeting	NNS	I-NP	O
.	.	.	O	O

Social	Social	JJ	B-NP	O
work	work	NN	I-NP	O
helped	help	VBD	B-VP	O
arranged	arrange	VBD	I-VP	O
a	a	DT	B-NP	O
medical	medical	JJ	I-NP	O
bed	bed	NN	I-NP	O
for	for	IN	B-PP	O
patient	patient	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
facilitate	facilitate	VB	I-VP	O
his	his	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
public	public	JJ	B-NP	O
housing	housing	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Followup	Followup	NN	B-NP	O
appts	appt	NNS	I-NP	O
were	be	VBD	B-VP	O
arranged	arrange	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Myles	Myles	NNP	I-NP	O
Mahnken	Mahnken	NNP	I-NP	O
Also	Also	NNP	I-NP	O
,	,	,	O	O
outpatient	outpatient	NN	B-NP	O
diabetes	diabetes	NN	I-NP	O
management	management	NN	I-NP	O
followup	followup	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
AHMH	AHMH	NN	I-NP	O
Endocrine	Endocrine	JJ	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appt	appt	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
within	within	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	B-VP	O
teach	teach	VB	I-VP	O
and	and	CC	I-VP	O
assist	assist	VB	I-VP	O
him	him	PRP	B-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
STOP	STOP	NN	B-NP	B-protein
taking	take	VBG	B-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
.	.	.	O	O

STOP	STOP	NN	B-NP	B-protein
taking	take	VBG	B-VP	O
your	your	PRP$	B-NP	O
metformin	metformin	NN	I-NP	O
and	and	CC	I-NP	O
gliburide	gliburide	NN	I-NP	O
.	.	.	O	O

CHANGE	CHANGE	VB	B-VP	O
your	your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
to	to	TO	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
40	40	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
30	30	CD	B-NP	O
units	unit	NNS	I-NP	O
before	before	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CURZI	CURZI	NNP	B-NP	O
,	,	,	O	O
YONG	YONG	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DO98	DO98	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/27/06	8/27/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

